Prolaris Test Helps ID Higher-risk Patients Who May Safely Skip ADT
News
Prolaris — a genetic test that predicts the aggressiveness of prostate cancer — can accurately identify which men with intermediate- or high-risk disease will benefit from adding androgen deprivation therapy (ADT) ... Read more